Anchalee Avihingsanon, HIV-NAT, Thai Red Cross AIDS Research Centre
HIV-NAT, Thai Red Cross AIDS Research CentreI am a specialist in infectious diseases. I have more than 10 years of experience working in the field of HIV/AIDS, tuberculosis and viral hepatitis research. I have published more than 100 research papers and co-investigated on more than 50 grants.
Presenter Of 2 Presentations
Oral abstract session
OAB0404 - Third-line antiretroviral therapy including raltegravir, darunavir/ritonavir and/or etravirine is well tolerated and achieves durable virologic suppression over 144+ weeks in resource limited settings ACTG: A5288 strategy trial
Session Name
Room
Abstract Sessions On-Demand Channel
E-Posters
PEB0182 - Increased epicardial adipose tissue volume in virally suppressed older HIV-infected Asian and Relationships to central fat accumulation and lipodystrophy
Session Name
E-posters Track B
Room
Poster Channel - Track B
Presenter Of 1 Presentation
Oral abstract session
Third-line antiretroviral therapy including raltegravir, darunavir/ritonavir and/or etravirine is well tolerated and achieves durable virologic suppression over 144+ weeks in resource limited settings ACTG: A5288 strategy trial
Session Name
Room
Abstract Sessions On-Demand Channel
Presenter Of 2 Presentations
Oral abstract session
Third-line antiretroviral therapy including raltegravir, darunavir/ritonavir and/or etravirine is well tolerated and achieves durable virologic suppression over 144+ weeks in resource limited settings ACTG: A5288 strategy trial
Session Name
Room
Abstract Sessions On-Demand Channel
E-Posters
Increased epicardial adipose tissue volume in virally suppressed older HIV-infected Asian and Relationships to central fat accumulation and lipodystrophy
Session Name
E-posters Track B
Room
Poster Channel - Track B